+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 2Years +
All Genders
ID07188532

Biologically-Adapted Dose-Escalated Radiotherapy and Surgery for Treating Patients with Ewing Sarcoma A Study Evaluating Radiotherapy Doses Based on Tumor Characteristics Conducted by Mayo Clinic

Led by Mayo Clinic · Updated on 2026-10-06

170

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating biologically-adapted, dose-escalated radiotherapy for treating patients with Ewing sarcoma, including those with large tumors and other tumor-specific characteristics. This study aims to reduce cancer recurrence at the primary tumor site and explores the role of biomarkers through blood and tumor tissue samples to better predict disease extent and return risk. The study is designed to compare different radiotherapy approaches based on tumor size and biology. Participants may receive standard chemotherapy every two weeks for at least three cycles before undergoing radiotherapy, which can be hypofractionated or conventional dose-escalated, delivered daily excluding weekends and holidays. The number of radiotherapy treatments ranges from 25 to 36 fractions depending on the group. Some may have surgical removal of the tumor and possibly consolidation chemotherapy after radiotherapy. Blood samples are collected throughout, and imaging tests like CT, PETCT, and MRI may be performed as needed. During the study, participants are monitored through regular blood sample collections and imaging scans at the discretion of their doctors. The researchers will measure outcomes such as the reduction in local tumor recurrence over two years, as well as survival rates and adverse events up to one year after local therapy. The entire participation may last several years with ongoing evaluations to understand treatment effects and safety.

CONDITIONS

Brief Title

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

Research Team

C

Clinical Trials Referral Office

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here